Cargando…
Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma
Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be i...
Autores principales: | , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Iranian Journal of Medical Sciences
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366370/ https://www.ncbi.nlm.nih.gov/pubmed/28360448 |
_version_ | 1782517579259052032 |
---|---|
author | Jain, Promil Sen, Rajeev Sharma, Nisha Bhargava, Shilpi Singh, Virender |
author_facet | Jain, Promil Sen, Rajeev Sharma, Nisha Bhargava, Shilpi Singh, Virender |
author_sort | Jain, Promil |
collection | PubMed |
description | Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be involved. Coexisting fibrosclerotic processes have been reported including retroperitoneal fibrosis, sclerosing cholangitis, sclerosing mediastinal fibrosis, and orbital pseudotumors. The etiology of this poorly understood entity remains unknown. Possible suggestions include exaggerated responses or autoimmune reactions to any chronic infection. The clinical and radiological appearance of TFLs is that of malignancy, but histopathology reveals them to be a benign process broadly classified under non-neoplastic, fibroinflammatory proliferations. The treatment strategies for these lesions are not well defined and variable and include steroids, surgery, and radiotherapy either alone or in combination. TFLs, albeit not fatal, have a high recurrence rate; patients should, therefore, be kept on long-term follow-up. We describe a young female patient presenting with a rapidly developing cheek swelling, which was diagnosed histopathologically as a TFLs. |
format | Online Article Text |
id | pubmed-5366370 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Iranian Journal of Medical Sciences |
record_format | MEDLINE/PubMed |
spelling | pubmed-53663702017-03-30 Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma Jain, Promil Sen, Rajeev Sharma, Nisha Bhargava, Shilpi Singh, Virender Iran J Med Sci Case Report Tumefactive fibroinflammatory lesions (TFLs) are rare idiopathic benign fibrosclerosing lesions that clinically simulate a malignancy. TFLs are seen more frequently in males between 10 and 74 years of age. The usual site of involvement is the head and neck region, but rarely the extremities may be involved. Coexisting fibrosclerotic processes have been reported including retroperitoneal fibrosis, sclerosing cholangitis, sclerosing mediastinal fibrosis, and orbital pseudotumors. The etiology of this poorly understood entity remains unknown. Possible suggestions include exaggerated responses or autoimmune reactions to any chronic infection. The clinical and radiological appearance of TFLs is that of malignancy, but histopathology reveals them to be a benign process broadly classified under non-neoplastic, fibroinflammatory proliferations. The treatment strategies for these lesions are not well defined and variable and include steroids, surgery, and radiotherapy either alone or in combination. TFLs, albeit not fatal, have a high recurrence rate; patients should, therefore, be kept on long-term follow-up. We describe a young female patient presenting with a rapidly developing cheek swelling, which was diagnosed histopathologically as a TFLs. Iranian Journal of Medical Sciences 2017-03 /pmc/articles/PMC5366370/ /pubmed/28360448 Text en Copyright: © Iranian Journal of Medical Sciences http://creativecommons.org/licenses/by-nc-sa/3.0 This is an open-access article distributed under the terms of the Creative Commons Attribution-Noncommercial-Share Alike 3.0 Unported, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Case Report Jain, Promil Sen, Rajeev Sharma, Nisha Bhargava, Shilpi Singh, Virender Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title | Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title_full | Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title_fullStr | Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title_full_unstemmed | Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title_short | Tumefactive Fibroinflammatory Lesion: A Diagnostic Dilemma |
title_sort | tumefactive fibroinflammatory lesion: a diagnostic dilemma |
topic | Case Report |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5366370/ https://www.ncbi.nlm.nih.gov/pubmed/28360448 |
work_keys_str_mv | AT jainpromil tumefactivefibroinflammatorylesionadiagnosticdilemma AT senrajeev tumefactivefibroinflammatorylesionadiagnosticdilemma AT sharmanisha tumefactivefibroinflammatorylesionadiagnosticdilemma AT bhargavashilpi tumefactivefibroinflammatorylesionadiagnosticdilemma AT singhvirender tumefactivefibroinflammatorylesionadiagnosticdilemma |